Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Phase 4, Single-Arm Clinical Trial to Evaluate Efficacy and Safety of Dymista (Azelastine Hydrochloride and Fluticasone Propionate) Nasal Spray in the Treatment of Allergic Rhinitis in Chinese Adolescents With or Without Ocular Symptoms.

NCT07597473 is registered in ClinicalTrials.gov with Viatris Inc. as lead sponsor.

NCT NCT07597473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07597473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Phase 4, Single-Arm Clinical Trial to Evaluate Efficacy and Safety of Dymista (Azelastine Hydrochloride and Fluticasone Propionate) Nasal Spray in the Treatment of Allergic Rhinitis in Chinese Adolescents With or Without Ocular Symptoms.
Lead sponsor
Viatris Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 8, 2026
Completion date
October 31, 2026
Enrollment
100 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to allergens